Switching to Antipsychotic Monotherapy Improves Cognitive Function & Social Activity


Researchers from Japan find that gradually eliminating one of two antipsychotics from the regimen of 39 patients with schizophrenia diagnoses results in improvements in tests of attention, daily living and work skills. Results appear in the Journal of Psychiatric Research.

Article →

Hori, H., Yoshimura, R., Katsuki, A., Sugita, A., et al; Switching to antipsychotic monotherapy can improve attention and processing speed, and social activity in chronic schizophrenia patients. Journal of Psychiatric Research. Online September 7, 2013

Previous articleBenzos Increase Risk of Fractures
Next article“Should We Stop Using Antipsychotic Medication?”
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected].